Xebra Brands Ltd
Xebra Brands Ltd. engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers i… Read more
Market Cap & Net Worth: Xebra Brands Ltd (XBRAF)
Xebra Brands Ltd (OTCQB:XBRAF) has a market capitalization of $475.05K ($475.05K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #48698 globally and #14959 in its home market, demonstrating a 72.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xebra Brands Ltd's stock price $0.06 by its total outstanding shares 8065442 (8.07 Million).
Xebra Brands Ltd Market Cap History: 2021 to 2025
Xebra Brands Ltd's market capitalization history from 2021 to 2025. Data shows change from $12.24 Million to $475.05K (-63.57% CAGR).
Xebra Brands Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xebra Brands Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.32x
Xebra Brands Ltd's market cap is 2.32 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $120.98K | $158.95K | -$4.02 Million | 0.76x | N/A |
| 2024 | $247.61K | $106.86K | -$1.96 Million | 2.32x | N/A |
Competitor Companies of XBRAF by Market Capitalization
Companies near Xebra Brands Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Xebra Brands Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Xebra Brands Ltd Historical Marketcap From 2021 to 2025
Between 2021 and today, Xebra Brands Ltd's market cap moved from $12.24 Million to $ 475.05K, with a yearly change of -63.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $475.05K | +91.86% |
| 2024 | $247.61K | +104.67% |
| 2023 | $120.98K | -86.63% |
| 2022 | $904.94K | -92.61% |
| 2021 | $12.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Xebra Brands Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $475.05K USD |
| MoneyControl | $475.05K USD |
| MarketWatch | $475.05K USD |
| marketcap.company | $475.05K USD |
| Reuters | $475.05K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.